Skip to content
Review Open access

The Cancer Cell Metabolic Reprogramming Remodels the Tumor Microenvironment: Molecular Mechanisms and Therapeutic Strategies

Aug 2026 · Advancement of science · 0 citations · 168 references
Medicine

TL;DR

This review elucidates the regulatory mechanisms by which glucose, lipids, amino acid metabolism, nucleotide metabolism, oxidative phosphorylation, lactate, and hypoxia modulate the proliferation, differentiation, and function of anti‐tumor immune cells and immunosuppressive cells.

Abstract

ABSTRACT Metabolic reprogramming and immune evasion are two key mechanisms that facilitate tumor progression. Tumor cells achieve their energy requirements for rapid proliferation through metabolic reprogramming, such as glucose metabolism, lipid metabolism, and amino acid metabolism. Tumor cell metabolic reprogramming can influence immune cell function in the tumor microenvironment through various mechanisms, ultimately facilitating tumor immune escape. Targeting tumor cell metabolism and combining metabolic regulation with immunotherapy can enhance anti‐tumor immune cells, inhibit the function of immunosuppressive cells, improve anti‐tumor therapy, and overcome immune escape. This review elucidates the regulatory mechanisms by which glucose, lipids, amino acid metabolism, nucleotide metabolism, oxidative phosphorylation, lactate, and hypoxia modulate the proliferation, differentiation, and function of anti‐tumor immune cells and immunosuppressive cells. Regulatory strategies to restore the anti‐tumor function of immune cells in response to metabolic changes were discussed. These strategies are expected to improve the effect of immunotherapy and are used in combination with other treatments to provide new ideas for cancer management.

Read PDF

Similar papers

Review Open access Aug 2026

Metabolic reprogramming and immune evasion interaction in the tumor microenvironment promote tumor progression

Emerging evidence demonstrates that tumor metabolic reprogramming not only supports tumor-cell proliferation but also promotes the establishment of an immunosuppressive tumor microenvironment (TME) by altering nutrient competition and metabolite accumulation. Therefore, metabolic reprogramming and immune evasion should...

Hai-Lun Wang, Han-Yuan Zhao, Xue-Lu Pu et al. · 0 citations
Review Open access Aug 2026

The Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment and the Mechanism of Immune Therapy Resistance

The article further explores therapeutic strategies targeting metabolic nodes such as lactate dehydrogenase A, CD73/CD39 - adenosine axis, to reverse immunosuppression and enhance the efficacy of ICIs, and looks forward to the future direction of using "metabolism-immunity" typing to guide individualized combination th...

Gan-Yu Yi · 0 citations
Review Open access Sep 2026

Metabolic Reprogramming and Tumor Immune Evasion in Oral Cancer from Molecular Mechanisms to Precision Therapeutic Strategies

Oral cancer remains a major malignancy of the head and neck region. Oral squamous cell carcinoma represents the predominant histological form and is characterized by substantial metabolic heterogeneity. Increasing evidence indicates that metabolic alterations are not simply secondary consequences of malignant transform...

Mohd Yusuf, Neha Ghode, Afreen Mondal et al. · 0 citations
Review Open access Aug 2026

Targeting the metabolic dependencies of tumor-associated macrophages for cancer immunotherapy

Tumor-associated macrophages (TAMs) play a pivotal role in tumor progression and immune evasion, with recent evidence indicating that metabolic reprogramming is crucial in determining their functional phenotype. Alterations in glucose, amino acid, and lipid metabolism are central to the regulation of TAMs plasticity,...

Wei-Feng Yuan, Yi-Ran Zhu, Yu-Xin Zhang et al. · 0 citations
Open access Sep 2026

Targeting Mitochondrial Metabolic Reprogramming: Reversing CD8⁺ T Cell Exhaustion and Improving Cancer Immunotherapy Response

This study explores the reversal effect of targeting mitochondrial metabolic reprogramming on CD8⁺ T cell exhaustion within the tumor microenvironment and its synergistic mechanism when combined with immune checkpoint blockade therapy. B16-OVA melanoma and LLC lung cancer tumor-bearing mouse models were established. Us...

Gang Liu, Jia Wang, A. Vasiukevich et al. · 0 citations
Review Open access Oct 2026

Metabolic immune checkpoints (MICs) in cancer: from molecular mechanisms to challenges and opportunities in clinical translation

Metabolic reprogramming is a core feature of tumor cells in adapting to microenvironmental stress and acquiring malignant phenotypes. It not only supports rapid proliferation but also mediates immune escape by reshaping the immune microenvironment. In recent years, the “metabolism-immune axis”, serving as a central hub...

Jin-Ru Yang, Xing Cai, Fa-Jian He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.